Assessment of Metastatic Cervical Adenopathy Using Dynamic Contrast-Enhanced MR Imaging

References

1. ↵
   Hao SP, Ng SH. Magnetic resonance imaging versus clinical palpation in evaluating cervical metastasis from head and neck cancer. Otolaryngol Head Neck Surg 2000;123:324–327

   Abstract/FREE Full Text
2. Kau RJ, Alexiou C, Stimmer H, Arnold W. Diagnostic procedures for detection of lymph node metastases in cancer of the larynx. ORL J Otorhinolaryngol Relat Spec 2000;62:199–203

   PubMed
3. ↵
   van den Brekel MW, Castelijns JA, Croll GA, et al. Magnetic resonance imaging vs palpation of cervical lymph node metastasis. Arch Otolaryngol Head Neck Surg 1991;117:663–673

   PubMed
4. ↵
   Som PM. Lymph nodes of the neck. Radiology 1987;165:593–600

   PubMedWeb of Science
5. ↵
   van den Brekel MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990;177:379–384

   PubMedWeb of Science
6. ↵
   Yousem DM, Som PM, Hackney DB, Schwaibold F, Hendrix RA. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 1992;182:753–759

   PubMedWeb of Science
7. ↵
   van den Brekel MW, Castelijns JA, Stel HV, et al. Detection and characterization of metastatic cervical adenopathy by MR imaging: comparison of different MR techniques. J Comput Assist Tomogr 1990;14:581–589

   CrossRefPubMedWeb of Science
8. ↵
   Curtin HD, Ishwaran H, Mancuso AA, Dalley RW, Caudry DJ, McNeil BJ. Comparison of CT and MR imaging in staging of neck metastases. Radiology 1998;207:123–130

   PubMedWeb of Science
9. ↵
   Benchaou M, Lehmann W, Slosman DO, et al. The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol 1996;116:332–335

   CrossRefPubMed
10. ↵
    Anzai Y, Prince MR. Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer. J Magn Reson Imaging 1997;7:75–81

    PubMed
11. ↵
    Tschammler A, Ott G, Schang T, Seelbach-Goebel B, Schwager K, Hahn D. Lymphadenopathy: differentiation of benign from malignant disease: color Doppler US assessment of intranodal angioarchitecture. Radiology 1998;208:117–123

    PubMedWeb of Science
12. Moritz JD, Ludwig A, Oestmann JW. Contrast-enhanced color Doppler sonography for evaluation of enlarged cervical lymph nodes in head and neck tumors. AJR Am J Roentgenol 2000;174:1279–1284

    CrossRefPubMedWeb of Science
13. ↵
    van den Brekel MW, Castelijns JA, Stel HV, et al. Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology 1991;180:457–461

    PubMedWeb of Science
14. ↵
    Parker GJ, Tofts PS. Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging. Top Magn Reson Imaging 1999;10:130–142
15. Roberts HC, Roberts TP, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000;21:891–899

    Abstract/FREE Full Text
16. ↵
    den Boer JA, Hoenderop RK, Smink J, et al. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions. J Magn Reson Imaging 1997;7:702–715

    PubMed
17. ↵
    Heiberg EV, Perman WH, Herrmann VM, Janney CG. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magn Reson Imaging 1996;14:337–348

    CrossRefPubMedWeb of Science
18. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999;10:260–266

    CrossRefPubMedWeb of Science
19. ↵
    Liney GP, Gibbs P, Hayes C, Leach MO, Turnbull LW. Dynamic contrast-enhanced MRI in the differentiation of breast tumors: user-defined versus semi-automated region-of-interest analysis. J Magn Reson Imaging 1999;10:945–949

    CrossRefPubMed
20. ↵
    Hawighorst H, Knapstein PG, Weikel W, et al. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. Radiology 1996;201:531–539

    PubMed
21. Mayr NA, Hawighorst H, Yuh WT, Essig M, Magnotta VA, Knopp MV. MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome. J Magn Reson Imaging 1999;10:267–276

    CrossRefPubMedWeb of Science
22. Lang P, Honda G, Roberts T, et al. Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement rates. Radiology 1995;197:831–839

    PubMed
23. ↵
    Barentsz JO, Engelbrecht M, Jager GJ, et al. Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging 1999;10:295–304

    CrossRefPubMed
24. ↵
    Kvistad KA, Rydland J, Smethurst HB, Lundgren S, Fjosne HE, Haraldseth O. Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 2000;10:1464–1471

    CrossRefPubMedWeb of Science
25. ↵
    Escott EJ, Rao VM, Ko WD, Guitierrez JE. Comparison of dynamic contrast-enhanced gradient-echo and spin-echo sequences in MR of head and neck neoplasms. AJNR Am J Neuroradiol 1997;18:1411–1419

    Abstract
26. Baba Y, Yamashita Y, Onomichi M, Murakami R, Takahashi M. Dynamic magnetic resonance imaging of head and neck lesions. Top Magn Reson Imaging 1999;10:125–129

    PubMed
27. ↵
    Baba Y, Furusawa M, Murakami R, et al. Role of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:783–787

    CrossRefPubMed
28. ↵
    Guckel C, Schnabel K, Deimling M, Steinbrich W. Dynamic snapshot gradient-echo imaging of head and neck malignancies: time dependency and quality of contrast-to-noise ratio. MAGMA 1996;4:61–69
29. ↵
    Hoskin PJ, Saunders MI, Goodchild K, Powell ME, Taylor NJ, Baddeley H. Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol 1999;72:1093–1098

    Abstract
30. ↵
    Takashima S, Noguchi Y, Okumura T, Aruga H, Kobayashi T. Dynamic MR imaging in the head and neck. Radiology 1993;189:813–821

    CrossRefPubMed
31. ↵
    Zagdanski AM, Sigal R, Bosq J, Bazin JP, Vanel D, Di Paola R. Factor analysis of medical image sequences in MR of head and neck tumors. AJNR Am J Neuroradiol 1994;15:1359–1368

    Abstract/FREE Full Text
32. ↵
    Henry RG, Fischbein NJ, Dillon WP, Vigneron DB, Nelson SJ. High-sensitivity coil array for head and neck imaging: technical note. AJNR Am J Neuroradiol 2001;22:1881–1886

    Abstract/FREE Full Text
33. ↵
    Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972;29:1446–1449

    CrossRefPubMedWeb of Science
34. ↵
    Wald LL, Carvajal L, Moyher SE, et al. Phased array detectors and an automated intensity correction algorithm for high resolution MR imaging of the human brain. Magn Reson Med 1995;34:433–439

    PubMed
35. ↵
    Nakayama E, Ariji E, Shinohara M, Yoshiura K, Miwa K, Kanda S. Computed tomography appearance of marked keratinization of metastatic cervical lymph nodes: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:321–326

    PubMed
36. ↵
    van den Brekel MW. Lymph node metastases: CT and MRI. Eur J Radiol 2000;33:230–238

    CrossRefPubMed
37. ↵
    Lamer S, Sigal R, Lassau N, et al. Radiologic assessment of intranodal vascularity in head and neck squamous cell carcinoma: correlation with histologic vascular density. Invest Radiol 1996;31:673–679

    PubMed
38. ↵
    Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–232

    CrossRefPubMedWeb of Science
39. ↵
    Vaupel P. Tumor blood flow. In: Molls M, Vaupel P, eds. Blood Perfusion and Microenvironment of Human Tumors. Berlin: Springer-Verlag;1998 :43
40. ↵
    Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Resom Imaging 1999;10:254–259

    CrossRefPubMedWeb of Science
41. ↵
    Milosevic MF, Fyles AW, Hill RP. The relationship between elevated interstitial fluid pressure and blood flow in tumors: a bioengineering analysis. Int J Radiat Oncol Biol Phys 1999;43:1111–1123

    CrossRefPubMed
42. ↵
    Rutz HP. A biophysical basis of enhanced interstitial fluid pressure in tumors. Med Hypotheses 1999;53:526–529

    PubMed
43. ↵
    Rijpkema M, Kaanders JH, Joosten FB, van der Kogel AJ, Heerschap A. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging 2001;14:457–463

    CrossRefPubMedWeb of Science
44. ↵
    Mozzillo N, Chiesa F, Botti G, et al. Sentinel node biopsy in head and neck cancer. Ann Surg Oncol 2001;8[suppl 9]:103S–105S.
45. ↵
    Taylor RJ, Wahl RL, Sharma PK, et al. Sentinel node localization in oral cavity and oropharynx squamous cell cancer. Arch Otolaryngol Head Neck Surg 2001;127:970–974

    PubMedWeb of Science